Cell Death Induced by Yersinia YopH
Cell Death Induced by Yersinia YopH
批准号:
6800912
负责人:
Tomas M Mustelin
金额:
$32.36万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2009-03-31
关键词:
T cell receptorT lymphocyteYersinia pestisantibacterial agentsapoptosisbacterial proteinsbiological signal transductionbioterrorism /chemical warfareconfocal scanning microscopydrug discovery /isolationhigh throughput technologyleukocyte activation /transformationnuclear magnetic resonance spectroscopyprotein tyrosine phosphataseproteomicssmall moleculevirulence
中文摘要
鼠疫杆菌是鼠疫或黑死病的病原,在历史上曾造成过其他任何传染病都无法比拟的毁灭性大流行。由于其快速复制和有效的免疫逃避能力,鼠疫耶尔森菌最近被认为是生物恐怖主义的潜在工具。特别是,细菌的雾化递送可能引起快速和暴发性肺炎感染,随后可能在人与人之间传播。虽然有几种疫苗存在,而且耶尔森氏菌通常对链霉素和四环素类抗生素敏感,但这种疾病的肺炎形式很难治疗,仍然经常导致死亡。额外的支持性治疗可能会显著降低这种死亡率,
英文摘要
Yersina pestis, the ethiologic agent of plague or Black Death, has in historical times caused devastating pandemics unrivaled by any other infectious disease. Due to its very rapid replication and effective immune evading capacity, Yersinia pestis has recently been recognized as a potential tool for bioterrorism. In particular, an aerosolized delivery of the bacterium could cause a rapid and fulminant pneumonic infection, which subsequently may spread from person to person. Although several vaccines exist and Yersinia usually is sensitive to streptomycin and tetracycline type antibiotics, the pneumonic form of the disease is difficult to treat and still often results in death. Additional supportive treatments may significantly reduce this lethality,
especially in the case of massive exposure of a population to weaponized Yersinia. This project focuses on a key component of the molecular machinery by which Yersinia pestis evades the immune system, a highly active protein tyrosine phosphatase (PTPase) termed YopH. In infected hosts, the bacteria multiply in lymph nodes, where they adhere to T and B cells and inject them with YopH. Inside the lymphocytes, YopH efficiently inhibits lymphocyte activation and the development of an immune response. We have found that YopH interferes with early T cell antigen receptor signaling and T cell survival. Our Specific Aims are: (1) Molecular targets of YopH in T cell antigen receptor signal transduction. These studies will attempt to determine the molecular mechanism by which YopH inhibits TCR-induced T cell activation using substrate-trapping technology, proteomics, tryptic peptide mapping, confocal microscopy, and functional assays and read-outs for T cell activation. (2) Mechanisms of cell cycle perturbation and cell death induced by YopH. We will investigate the role of nuclear YopH and the mechanism of YopH-induced cell death by a combination of imaging, biochemistry, proteomics, and functional assays for cell death. (3) Development of a YopH-specific inhibitor. In close collaborations within this P01, we will develop YopH-specific small molecule inhibitors by combinations of high through-put screening, NMR, virtual docking, and constrained peptide chemistry. Leads will be optimized and taken through counter-screening with other PTPases and functional tests in YopH-expressing T cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of the L1 retrotransposon in interferon-positive SLE
-
批准号:10603189
-
项目类别:
-
资助金额:$54.75万
-
财政年份:2022
-
负责人:Tomas M Mustelin
-
依托单位:
HERV-K immunity, a trigger of citrullination in rheumatoid arthritis?
-
批准号:10402763
-
项目类别:
-
资助金额:$19.22万
-
财政年份:2021
-
负责人:Tomas M Mustelin
-
依托单位:
Role of protein citrullination in rheumatoid arthritis
-
批准号:10548134
-
项目类别:
-
资助金额:$38.83万
-
财政年份:2020
-
负责人:Tomas M Mustelin
-
依托单位:
Role of protein citrullination in rheumatoid arthritis
-
批准号:9883195
-
项目类别:
-
资助金额:$38.83万
-
财政年份:2020
-
负责人:Tomas M Mustelin
-
依托单位:
Role of protein citrullination in rheumatoid arthritis
-
批准号:10091400
-
项目类别:
-
资助金额:$37.67万
-
财政年份:2020
-
负责人:Tomas M Mustelin
-
依托单位:
Role of protein citrullination in rheumatoid arthritis
-
批准号:10318576
-
项目类别:
-
资助金额:$38.44万
-
财政年份:2020
-
负责人:Tomas M Mustelin
-
依托单位:
The roots of SLE: Can we cure it with a reverse transcriptase inhibitor?
-
批准号:9922870
-
项目类别:
-
资助金额:$19.42万
-
财政年份:2019
-
负责人:Tomas M Mustelin
-
依托单位:
CORE 3C: INFRASTRUCTURE PROTEOMICS
-
批准号:7725965
-
项目类别:
-
资助金额:$12.13万
-
财政年份:2008
-
负责人:Tomas M Mustelin
-
依托单位:
CORE 3C: INFRASTRUCTURE PROTEOMICS
-
批准号:7622863
-
项目类别:
-
资助金额:$11.62万
-
财政年份:2007
-
负责人:Tomas M Mustelin
-
依托单位:
CORE 3C: INFRASTRUCTURE PROTEOMICS
-
批准号:7380834
-
项目类别:
-
资助金额:$12.53万
-
财政年份:2006
-
负责人:Tomas M Mustelin
-
依托单位:
CORE 3C: INFRASTRUCTURE PROTEOMICS
-
批准号:7167090
-
项目类别:
-
资助金额:$11.24万
-
财政年份:2005
-
负责人:Tomas M Mustelin
-
依托单位:
CORE--Shared Resources Proteomics
-
批准号:6990469
-
项目类别:
-
资助金额:$11.08万
-
财政年份:2004
-
负责人:Tomas M Mustelin
-
依托单位:
PTP-MEG2: Regulation, Substrates, Biology
-
批准号:6844731
-
项目类别:
-
资助金额:$33.43万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
Regulation of the tumor suppressor PTEN
-
批准号:7004490
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
Negative regulation of TCR-associated PTKs
-
批准号:6824908
-
项目类别:
-
资助金额:$48.0万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
Negative regulation of TCR-associated PTKs
-
批准号:6983414
-
项目类别:
-
资助金额:$46.87万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
Regulation of the tumor suppressor PTEN
-
批准号:6839424
-
项目类别:
-
资助金额:$34.18万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
Regulation of the tumor suppressor PTEN
-
批准号:6581980
-
项目类别:
-
资助金额:$34.18万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
PTP-MEG2: Regulation, Substrates, Biology
-
批准号:7008879
-
项目类别:
-
资助金额:$32.64万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
Regulation of the tumor suppressor PTEN
-
批准号:6694027
-
项目类别:
-
资助金额:$34.18万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
海外基金